Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-inflammatory potentials of incretin-based therapies used in the management of diabetes
Habib Yaribeygi, Mina Maleki, Thozhukat Sathyapalan, et al.
Life Sciences (2019) Vol. 241, pp. 117152-117152
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists
Giulia Bendotti, Laura Montefusco, Maria Elena Lunati, et al.
Pharmacological Research (2022) Vol. 182, pp. 106320-106320
Closed Access | Times Cited: 141
Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence
Radica Z. Alicic, Emily J. Cox, Joshua J. Neumiller, et al.
Nature Reviews Nephrology (2020) Vol. 17, Iss. 4, pp. 227-244
Closed Access | Times Cited: 126
Anti-inflammatory benefits of semaglutide: State of the art
Habib Yaribeygi, Mina Maleki, Tannaz Jamialahmadi, et al.
Journal of Clinical & Translational Endocrinology (2024) Vol. 36, pp. 100340-100340
Open Access | Times Cited: 10
Modern Management of Cardiometabolic Continuum: From Overweight/Obesity to Prediabetes/Type 2 Diabetes Mellitus. Recommendations from the Eastern and Southern Europe Diabetes and Obesity Expert Group
Andrej Janež, Emir Muzurović, Paweł Bogdański, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 9, pp. 1865-1892
Open Access | Times Cited: 10
The central role of the gut microbiota in the pathophysiology and management of type 2 diabetes
Daniel P Baars, Marcos F. Fondevila, Abraham S. Meijnikman, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 8, pp. 1280-1300
Closed Access | Times Cited: 8
Chia flour (Salvia hispanica)—based snacks and a restrictive diet reduce the cardiovascular risk factors associated with diabetes mellitus type 2 in adults
A Sosa, Edwin E. Martínez Leo, Rafael Rojas-Herrera, et al.
Elsevier eBooks (2025), pp. 259-271
Closed Access
GLP-1 mimetics and cognition
Habib Yaribeygi, Ali Rashidy‐Pour, Stephen L. Atkin, et al.
Life Sciences (2020) Vol. 264, pp. 118645-118645
Closed Access | Times Cited: 61
Relationship Between Diabetes Mellitus and Periodontal/Peri-Implant Disease: A Contemporaneous Review
Shabnam Enteghad, Farinaz Shirban, Mohammad Hossein Nikbakht, et al.
International Dental Journal (2024) Vol. 74, Iss. 3, pp. 426-445
Open Access | Times Cited: 5
NLRP3 inflammasomes pathway: a key target for Metformin
Yasamin Hosseini, Amirhossein Niknejad, Ayeh Sabbagh Kashani, et al.
Inflammopharmacology (2025)
Closed Access
GLP-1 Receptor Agonist Effects on Lipid and Liver Profiles in Patients with Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
Shahla Rezaei, Reza Tabrizi, Peyman Nowrouzi‐Sohrabi, et al.
Canadian Journal of Gastroenterology and Hepatology (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 39
The Role of Glucagon-Like Peptide-1 Receptor Agonists in Chronic Obstructive Pulmonary Disease
Wenwen Wang, Aihua Mei, Hang Qian, et al.
International Journal of COPD (2023) Vol. Volume 18, pp. 129-137
Open Access | Times Cited: 13
Therapeutic effects of anti-diabetic drugs on traumatic brain injury
Seyed Mehrad Razavi, Zahra Najafi Arab, Amirhossein Niknejad, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 2, pp. 102949-102949
Closed Access | Times Cited: 4
Glp-1 Mimetics and Autophagy in Diabetic Milieu: State-of-the-Art
Habib Yaribeygi, Mina Maleki, Raul D. Santos, et al.
Current Diabetes Reviews (2024) Vol. 20, Iss. 10
Closed Access | Times Cited: 4
The effect of glucagon‐like peptide‐1 receptor agonists on serum uric acid concentration: A systematic review and meta‐analysis
Sara Najafi, Milad Bahrami, Alexandra E. Butler, et al.
British Journal of Clinical Pharmacology (2022) Vol. 88, Iss. 8, pp. 3627-3637
Open Access | Times Cited: 18
Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney disease
Radica Z. Alicic, Joshua J. Neumiller, Katherine R. Tuttle
Current Opinion in Nephrology & Hypertension (2023)
Open Access | Times Cited: 10
The Impact of Diabetes Mellitus in COVID-19: A Mechanistic Review of Molecular Interactions
Habib Yaribeygi, Thozhukat Sathyapalan, Tannaz Jamialahmadi, et al.
Journal of Diabetes Research (2020) Vol. 2020, pp. 1-9
Open Access | Times Cited: 26
Glucagon-like peptide-1 receptor agonist liraglutide therapy for psoriasis patients with type 2 diabetes: a randomized-controlled trial
Lu Lin, Xiangjin Xu, Yu Yunjie, et al.
Journal of Dermatological Treatment (2020) Vol. 33, Iss. 3, pp. 1428-1434
Closed Access | Times Cited: 25
Exenatide extended release in patients with type 1 diabetes with and without residual insulin production
Kevan C. Herold, Jesse Reynolds, James Dziura, et al.
Diabetes Obesity and Metabolism (2020) Vol. 22, Iss. 11, pp. 2045-2054
Open Access | Times Cited: 24
The role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanism
Yajnavalka Banerjee, Anca Pantea Stoian, José Silva‐Nunes, et al.
Expert Opinion on Drug Safety (2021) Vol. 20, Iss. 11, pp. 1309-1315
Open Access | Times Cited: 22
The Impact of Incretin-Based Medications on Lipid Metabolism
Habib Yaribeygi, Mina Maleki, Alexandra E. Butler, et al.
Journal of Diabetes Research (2021) Vol. 2021, pp. 1-10
Open Access | Times Cited: 20
Glucagon‐like peptide‐1: Are its roles as endogenous hormone and therapeutic wizard congruent?
Jens J. Holst
Journal of Internal Medicine (2022) Vol. 291, Iss. 5, pp. 557-573
Closed Access | Times Cited: 14
The SLC6A15–SLC6A20 Neutral Amino Acid Transporter Subfamily: Functions, Diseases, and Their Therapeutic Relevance
Jędrzej Kukułowicz, Krzysztof Pietrzak-Lichwa, Klaudia Klimończyk, et al.
Pharmacological Reviews (2023) Vol. 76, Iss. 1, pp. 142-193
Open Access | Times Cited: 8
Semaglutide Alleviates Ovary Inflammation via the AMPK/SIRT1/NF‑κB Signaling Pathway in Polycystic Ovary Syndrome Mice
Mei Liu, Sili Guo, Xiaohan Li, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 3925-3938
Open Access | Times Cited: 2
Pyrazole Incorporated New Thiosemicarbazones: Design, Synthesis and Investigation of DPP-4 Inhibitory Effects
Belgin Sever, Hasan Soybir, Şennur Görgülü, et al.
Molecules (2020) Vol. 25, Iss. 21, pp. 5003-5003
Open Access | Times Cited: 21
Antioxidative Potentials of Incretin‐Based Medications: A Review of Molecular Mechanisms
Habib Yaribeygi, Mina Maleki, Thozhukat Sathyapalan, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top